Efficacy and safety of novel twincretin tirzepatide a dual GIP and GLP-1 receptor agonist in the management of type-2 diabetes: a Cochrane meta-analysis - Dutta, D; Surana, V; Singla, R; Aggarwal, S; Sharma, M (Indian J Endocrinol Metab, 2021)